EcoDrugPlus

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSSMAG00000006862
Gene Symbol: CDK9
2 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSSMAG00000034053
Gene Symbol: LOC118320195
2 Cross references
237 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSSMAG00000007092
Gene Symbol: CDAB
3 Cross references
200 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSSMAG00000012274
Gene Symbol: CYP19A1
1 Cross references
244 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSSMAG00000001013
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSSMAG00000014538
Gene Symbol: CYP19A1A
1 Cross references
249 Possible Orthologues:

Cytochrome P450, Family 26, Subfamily A, Polypeptide 1

Ensembl ID : ENSSMAG00000000849
Gene Symbol: CYP26A1
1 Cross references
194 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSMAG00000017849
Gene Symbol: LOC118287703
2 Cross references
197 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSMAG00000019213
Gene Symbol: LOC118291354
3 Cross references
190 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSMAG00000005178
Gene Symbol: LOC118291646
3 Cross references
191 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSSMAG00000021359
Gene Symbol: DHODH
2 Cross references
172 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSMAG00000000959
Gene Symbol: LOC118309200
2 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).